Retraction: Chamaejasmin B decreases malignant characteristics of mouse melanoma B16F0 and B16F10 cells - Summary - MDSpire

Retraction: Chamaejasmin B decreases malignant characteristics of mouse melanoma B16F0 and B16F10 cells

  • April 30, 2026

  • 0 min

Share

Objective:

To investigate the effects of Chamaejasmin B on malignant characteristics in mouse melanoma cell lines, while addressing ethical concerns that led to the study's retraction.

Key Findings:
  • Concerns were raised regarding the integrity of the figures and ethical oversight.
  • Tumor sizes exceeded internationally accepted animal welfare limits.
  • Experiments did not adhere to the approved protocols by the Shihezi University Animal Care and Use Committee.
  • The authors acknowledged these breaches during the investigation.
Interpretation:

The findings indicate a significant breach of ethical standards in the conduct of the study, leading to its retraction as a necessary response to uphold research integrity.

Limitations:
  • Lack of adherence to ethical guidelines.
  • Integrity issues with the data presented.
  • These limitations undermine the validity of the study's findings.
Conclusion:

The article has been retracted due to ethical violations and integrity concerns, as confirmed by an investigation, highlighting the critical importance of ethical compliance in research.

Original Source(s)

Related Content